Galenica

Galenica is the leading fully-integrated healthcare provider in Switzerland. With over 500 own, joint venture and independent partner pharmacies, Galenica operates the largest network of pharmacies in Switzerland. In addition, Galenica further develops and offers well-known own brands and products, exclusive brands and products from business partners as well as a variety of on-site health services and tests for customers. Galenica is also the leading provider of pre-wholesale and wholesale distribution as well as database services in the Swiss healthcare market. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446).

Ferring Pharmaceuticals

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines Social Media Privacy Notice available here: https://www.ferring.com/social-media-privacy-notice/

Mensa Group

The group of companies that is today known as MENSA GROUP started through the establishment of PT Menjangan Sakti by its founder – Mr. Jimmy Sudharta in April 1975. The company started its business by trading pharmaceutical raw materials throughout Indonesia. With time the company expanded its business and diversified its activity to include the cosmetic, food and feed industries. Continuous growth of PT Menjangan Sakti has provided the company the ability and resources to expand into related business. Starting 1981, PT Menjangan Sakti acquired several other companies in related activity including pharmaceutical manufacturing companies and Distribution Company, forming what is today known as Mensa Group. Mensa Group comprises of several companies with diversified activity such as: - importing and trading pharmaceutical raw materials including food, feed and cosmetics; - pharmaceutical manufacturing ; - medical supplies and dental equipment manufacturing; - Pharmaceutical, hospital / medical supplies and consumer goods distribution. The group employs approximately 5000 employees, and main aim in the near future is to establish a solid synergy between the companies and amongst other to develop a nationwide distribution network as an asset for further growth.

evotec bridges

A BRIDGE (Biomedical Research, Innovation & Development Generation Efficiency) is an integrated fund and award framework to accelerate the translation of early-stage drug discovery from academia to pharma. The goal of our BRIDGE pre-seed partnerships is to unlock the potential of academic innovation from therapeutic concept to investable data point by making our know-how in drug discovery, our technology platforms and matched funding readily available to academic researchers.

celgene

We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl